Crossmark

The PERK inhibitor GSK2606414 evokes developmental defects in zebrafish consistent with Wolcott-Rallison syndrome phenotypes

Crossref DOI link: https://doi.org/10.1007/s43440-026-00837-7

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Almeida, Liliana M. https://orcid.org/0000-0003-1042-511X
Lima, Leonor Pereira https://orcid.org/0000-0003-3454-1799
Oliveira, Nuno A. S. https://orcid.org/0000-0002-0735-8457
Silva, Rui F. O. https://orcid.org/0000-0001-5470-778X
Sousa, Bruno https://orcid.org/0000-0002-3995-8545
Bessa, José https://orcid.org/0000-0002-8591-7138
Pinho, Brígida R. https://orcid.org/0000-0002-1627-6795
Oliveira, Jorge M. A. https://orcid.org/0000-0002-6040-5355
Funding

Funding for this research was provided by:

Universidade do Porto
License Information

Text and Data Mining valid from 2026-02-13

Version of Record valid from 2026-02-13
More Information

Article History

Received: 28 July 2025

Revised: 7 February 2026

Accepted: 7 February 2026

First Online: 13 February 2026

Declarations

:

: The authors declare no competing interests.